Gene · 2171
Papers2,434
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,434
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Direct sensing of dietary ω-6 linoleic acid through FABP5-mTORC1 signaling. | Science | 2025 | 40080571 | PubTator, text mining | PubMed |
| SMYD3 Activates Fatty Acid β-Oxidation to Promote Self-Renewal of Leukemia Stem Cells. | Cancer Res | 2025 | 40080525 | PubTator, text mining | PubMed |
| Expression and Secretion of Intraocular Fatty Acid-Binding Protein 4 (ioFABP4) and 5 (ioFABP5) Are Regulated by Glucose Levels and Fatty Acids. | Int J Mol Sci | 2025 | 40076418 | PubTator, text mining | PubMed |
| GPR171 restrains intestinal inflammation by suppressing FABP5-mediated Th17 cell differentiation and lipid metabolism. | Gut | 2025 | 40074327 | PubTator, text mining | PubMed |
| Fatty acid binding protein 5 inhibitors as novel anticancer agents against metastatic castration-resistant prostate cancer. | Bioorg Med Chem | 2025 | 40058274 | PubTator, text mining | PubMed |
| Molecular Markers of Occult Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma (HNSCC) Patients. | Front Biosci (Landmark Ed) | 2025 | 40018925 | PubTator, text mining | PubMed |
| Single-cell and spatial analysis reveals the interaction between ITLN1+ foam cells and SPP1+ macrophages in atherosclerosis. | Front Cardiovasc Med | 2025 | 40017519 | PubTator, text mining | PubMed |
| FABP5 is a key player in metabolic modulation and NF-κB dependent inflammation driving pleural mesothelioma. | Commun Biol | 2025 | 40016284 | PubTator, text mining | PubMed |
| SBFI-26 enhances apoptosis in docetaxel-treated triple-negative breast cancer cells by increasing ROS levels. | Bioimpacts | 2025 | 39963566 | PubTator, text mining | PubMed |
| Modulating the PD-1-FABP5 axis in ILC2s to regulate adipose tissue metabolism in obesity. | Mol Ther | 2025 | 39949060 | PubTator, text mining | PubMed |
| USP14 targets FABP5-mediated ferroptosis to promote proliferation and cisplatin resistance of HNSCC. | Clin Transl Oncol | 2025 | 39928282 | PubTator, text mining | PubMed |
| Integration of single-cell and bulk transcriptomics reveals β-hydroxybutyrylation-related signatures in primary open-angle glaucoma. | Exp Eye Res | 2025 | 39922523 | PubTator, text mining | PubMed |
| Cellular heterogeneity and communication networks in gastric cancer: Single-cell analysis reveals β-hydroxybutyrylation-associated genes and immune infiltration characteristics. | Transl Oncol | 2025 | 39884220 | PubTator, text mining | PubMed |
| MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignancies. | Mil Med Res | 2025 | 39871325 | PubTator, text mining | PubMed |
| Comprehensive analysis reveals cholesterol metabolism-related signature for predicting prognosis and guiding individualized treatment of glioma. | Heliyon | 2025 | 39866460 | PubTator, text mining | PubMed |
| VAMP8 as a biomarker and potential therapeutic target for endothelial cell dysfunction in atherosclerosis. | Gene | 2025 | 39800194 | PubTator, text mining | PubMed |
| FABP5 regulates ROS-NLRP3 inflammasome in glutamate-induced retinal excitotoxic glaucomatous model. | FASEB J | 2025 | 39792326 | PubTator, text mining | PubMed |
| Intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut-liver axis. | Nat Metab | 2025 | 39779889 | PubTator, text mining | PubMed |
| Repeated Injection of Xylazine Causes Liver Injury Through the PPAR Signaling Pathway in Rats. | J Biochem Mol Toxicol | 2025 | 39692361 | PubTator, text mining | PubMed |
| Macrophage Evolution during Progression of Hepatitis Virus B-Related Acute-on-Chronic Liver Failure. | J Innate Immun | 2025 | 39637841 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2171/papers?page=10